Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

Neglected diseases represent a major health problem. It is estimated that one third of the world population is infected with tuberculosis (TB). Besides TB, Chagas disease, affects approximately 20 million people. Quinoxalines display great activities against TB and Chagas. Forty new quinoxaline 1...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Ancizu, S. (Saioa), Moreno-de-Viguri, E. (Elsa), Torres, E. (Enrique), Burguete, A. (Asunción), Pérez-Silanes, S. (Silvia), Benitez, D. (Diego), Raquel, Solano, B. (Beatriz), Marin, A. (Adoración), Aldana, I. (Ignacio), Cerecetto, H. (Hugo), Gonzalez, M. (Mercedes), Monge, A. (Antonio)
Fformat: info:eu-repo/semantics/article
Iaith:eng
Cyhoeddwyd: MDPI 2012
Pynciau:
Quinoxaline
Neglected diseases
Mycobacterium tuberculosis
Trypanosoma cruz
Mynediad Ar-lein:https://hdl.handle.net/10171/23599

Rhyngrwyd

https://hdl.handle.net/10171/23599

Eitemau Tebyg